• News
  • SAN DIEGO
  • Medical

Organovo Holdings, ZenBio partnering for 3-D tissue

San Diego-based Organovo Holdings Inc. (OTCQX: ONVO) and ZenBio Inc. are partnering to produce three-dimensional human tissues for drug discovery and advanced tissue therapies.

Organovo Holdings is a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications.

ZenBio Inc. provides advanced cell-based solutions and services.

ZenBio will provide validated cellular inputs for use by Organovo with its NovoGen bioprinting technology to enable the generation of living, three-dimensional tissues that reproduce the architectural and functional features of tissues inside the human body.

The resulting 3-D tissue models may lead to advances in medical research, drug discovery and development, as well as direct therapies and transplantation, according to Organovo.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Organovo Holdings Inc.

Company Website

6275 Nancy Ridge Dr. Ste., 110
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ONVO
3.25
  -0.03  
- 0.91%
715,412,000
7.68
1.9

Organovo Holdings Inc. Executive(s):

Keith Murphy

  • Chairman, Chief Executive Officer

Barry Michaels

  • Chief Financial Officer
Subscribe Today!